Cite
The influence of vitreomacular adhesion on outcomes after aflibercept therapy for neovascular age-related macular degeneration
MLA
Thomas A. Willis, et al. The Influence of Vitreomacular Adhesion on Outcomes after Aflibercept Therapy for Neovascular Age-Related Macular Degeneration. Apr. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....37535da9e52215abdc506002f0472af5&authtype=sso&custid=ns315887.
APA
Thomas A. Willis, Carlo A. Suter, & Martin McKibbin. (2015). The influence of vitreomacular adhesion on outcomes after aflibercept therapy for neovascular age-related macular degeneration.
Chicago
Thomas A. Willis, Carlo A. Suter, and Martin McKibbin. 2015. “The Influence of Vitreomacular Adhesion on Outcomes after Aflibercept Therapy for Neovascular Age-Related Macular Degeneration,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....37535da9e52215abdc506002f0472af5&authtype=sso&custid=ns315887.